Biocardia Directors Make Significant Stock Purchases, Signaling Confidence in Future

Biocardia's directors, Stertzer and Blank, have recently invested a combined total of $858,000 in company shares, reflecting strong confidence in the firm's future. Stertzer purchased $498,000 worth of shares, while Blank acquired $360,000 in common stock. These insider purchases are expected to enhance market sentiment and attract further investments, marking a positive development for Biocardia and its stakeholders.